Neoadjuvant immuno-chemo-radiotherapy in operable esophageal and gastroesophageal junction adenocarcinoma with carboplatin, paclitaxel plus radiotherapy and avelumab (anti-PDL1 antibody): Neo-CREATE ...
Metronomic chemotherapy with capecitabine (Xeloda) plus an aromatase inhibitor (AI) could be a first-line treatment option for some patients with HR-positive, HER2-negative metastatic breast cancer, ...
Patients with early-stage triple-negative breast cancer (TNBC) and high immune infiltration showed improved disease-free survival (DFS) with adjuvant capecitabine. These “immune-hot” patients had a ...
MedPage Today on MSN
Intensified Pre-Op Chemoradiotherapy Fails in Locally Advanced Rectal Cancer
DFS at 3 years nearly identical with the addition of irinotecan, but with more toxicity ...
Barriers to Prescribing Targeted Therapies for Patients With NSCLC With Highly Actionable Gene Variants in the Veterans Affairs National Precision Oncology Program Increasing use of oral chemotherapy ...
Oral vitamin B12 supplements may offer an additional way to prevent hand-foot syndrome, a common side effect of chemotherapy with capecitabine, a clinical trial suggested. The phase 3 trial, conducted ...
LONDON (MarketWatch) -- Swiss drug giant Roche said Tuesday that it has filed licence extensions for its anti-angiogenic agent Avastin (bevacizumab) and oral chemotherapy, Xeloda (capecitabine). The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results